MKI67 and neoplasm: The results of immunohistochemical analysis revealed that the number of hyperproliferative BrdU- and Ki67-positive tumor cells in two CIK-treated groups were significantly decreased compared with control (Fig. 7F), while the percentages of BrdU- and Ki67-positive tumor cells between two CIK-treated groups became statistically significant (Fig. 7F).